Skip to main content

Table 4 Comparison of three matched cohorts on their pre-index date continuous match variables using paired t-tests.

From: Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

Pre-Index Continuous Variables

LABA or LAMATx

LABA and LAMA Tx

LABA, LAMA, and ICS Tx

Significant Pairwise Paired t-tests*

 

(n = 523)

(n = 523)

(n = 523)

 
 

LS Mean (SE)

LS Mean (SE)

LS Mean (SE)

 

Age

70.0

(9.4)

70.7

(9.4)

70.4

(9.3)

NONE

Rx comorbidity score

6.2

(2.6)

6.4

(2.8)

6.2

(2.6)

NONE

% Days COPD medication exposure

64.3

(32.3)

66.3

(33.8)

63.2

(32.8)

DvT

Average copay amount

12.9

(12.4)

13.9

(13.4)

14.0

(12.4)

NONE

Total COPD-related costs

1,895.9

(1914.5)

1,987.7

(2411.5)

1,973.1

(2216.6)

NONE

Number of hospital visits

0.2

(0.5)

0.2

(0.5)

0.2

(0.5)

NONE

Number of days in hospital

0.8

(2.5)

0.8

(2.3)

0.6

(2.3)

NONE

Number of emergency room visits

0.5

(1.1)

0.4

(1.0)

0.4

(0.8)

NONE

Number of outpatient visits

21.7

(16.8)

22.4

(16.7)

20.9

(18.8)

NONE

  1. *Pairwise paired t-tests for dependent measures were conducted and pairs resulting in a significant p-value are listed (M = LABA or LAMA, D = LABA and LAMA, T = LABA, LAMA, ICS, NONE = No sig dif). All variables were derived from the 12 month pre-period.